Back to User profile » Mr Paul Gomes
Papers published by Mr Paul Gomes:
Statistical Evaluation of Smartphone-Based Automated Grading System for Ocular Redness Associated with Dry Eye Disease and Implications for Clinical Trials
Rodriguez JD, Hamm A, Bensinger E, Kerti SJ, Gomes PJ, Ousler III GW, Gupta P, De Moraes CG, Abelson MB
Clinical Ophthalmology 2025, 19:907-914
Published Date: 13 March 2025
A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis
Kenyon K, McLaurin EB, Silverstein SM, Meyer JC, Anderson E, Patel RH, Gomes PJ, Reilly E, Vantipalli S, Cheung MW, Goldstein MH
Clinical Ophthalmology 2024, 18:2671-2684
Published Date: 21 September 2024
Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube®: a randomized clinical trial
Gomes PJ, Abelson MB, Stein L, Viirre E, Villafranca JE, Lasser EC
Journal of Asthma and Allergy 2019, 12:71-81
Published Date: 1 March 2019
Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects
Malhotra RP, Meier E, Torkildsen G, Gomes PJ, Jasek MC
Clinical Ophthalmology 2019, 13:403-413
Published Date: 19 February 2019
Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model
Meier EJ, Torkildsen GL, Gomes PJ, Jasek MC
Clinical Ophthalmology 2018, 12:2617-2628
Published Date: 13 December 2018
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
McLaurin E, Bergmann M, Narvekar A, Adewale A, Gomes P, Torkildsen G
Clinical Ophthalmology 2017, 11:1089-1097
Published Date: 8 June 2017
Technical and clinical validation of an environmental exposure unit for ragweed
Gomes PJ, Lane KJ, Angjeli E, Stein L, Abelson MB
Journal of Asthma and Allergy 2016, 9:215-221
Published Date: 14 December 2016
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
Bergmann MT, Williams JI, Gomes PJ
Clinical Ophthalmology 2014, 8:1495-1505
Published Date: 13 August 2014
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
Gomes PJ, Ousler GW, Welch DL, Smith LM, Coderre J, Abelson MB
Clinical Ophthalmology 2013, 7:157-165
Published Date: 20 January 2013